SPHRF Stock UPDATES Starpharma Holdings (SPHRF) 0.6800 09/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Starpharma Holdings (SPHRF) 0.6800 $SPHRF

FDA Grants Special Protocol Assessment (SPA) Agreement for Starpharma Phase 3 Recurrent BV Trial
Business Wire - Mon Jul 14, 4:35AM CDT
Starpharma Holdings Ltd (ASX:SPL) (OTCQX:SPHRY) today announced that the US Food and Drug Administration (FDA) has granted Special Protocol Assessment (SPA) agreement on the design and planned analyses of the phase 3 clinical studies of the VivaGel(R) bacterial vaginosis (BV) product for the prevention of recurrent BV.

New IGP Sets His Priorities, Warns Unethical Officers
by Abdulwakil Saiboko - All Africa Global Media - Thu Jan 09, 10:36PM CST
THE newly-appointed Inspector- General of Police (IGP), Mr Ernest Mangu, has outlined his priorities, warning police over unethical behaviour, saying severe measures will be taken against violators.

The Ellen's Corkrum Recordings and Its Legal Implication [opinion]
by Dashward A. Wumah - All Africa Global Media - Fri Dec 20, 6:34AM CST
In the wake of Ellen Corkrum, former head of the Liberia Airport Authority, and her fiance Melvin Johnson, secret recordings of Musa Bility former Chairman of the Board of Directors of the Liberia Airport Authority (LAA), along with others accused by the Government of Liberia for Economic Sabotage in the tune of over US$1 million. (All Africa 2013), the secret recordings of Defense Minister, Brownie Samukai, and Mr. Chris Massaquoi, the Inspector General of the Liberia National Police

Genital Herpes - Pipeline Review, H2 2013 Reviews Key Players Involved In the Therapeutic Development for Genital Herpes
M2 - Tue Sep 03, 4:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r3z3pp/genital_herpes) has announced the addition of the "Genital Herpes - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Genital Herpes - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. Genital Herpes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Genital Herpes. - A review of the Genital Herpes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Genital Herpes pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned: - AiCuris GmbH & Co. KG - Antigenics, Inc. - Flamel Technologies S.A. - Foamix Ltd. - NanoViricides, Inc. - Profectus BioSciences, Inc. - Starpharma Holdings Limited - Wittycell S.A.S. For more information visit http://www.researchandmarkets.com/research/r3...tal_herpes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Starpharma and Makhteshim Agan in Priostar Agrochemical Collaboration
PR Newswire - Wed Mar 13, 3:02AM CDT
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) and Makhteshim Agan Group today announced a collaboration program. This will see Starpharma's Priostar® dendrimer technology applied to novel crop protection formulations across Makhteshim Agan's extensive product portfolio.

Herpes Simplex Virus Treatment - Global Strategic Business Report
M2 - Thu Feb 14, 6:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/3fnf3m/herpes_simplex) has announced the addition of the "Herpes Simplex Virus Treatment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. Key Topics Covered I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Treatment Of Herpes Simplex Virus Infection 3. Hsv Vaccines - An Insight 4. Herpes Simplex Virus Infection - The Disease, Causes, Symptoms, And Diagnosis 5. Pipeline Analysis 6. Product Launche




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 104

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 105

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 55

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 340

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 87

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 197

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading

Top 5 Most Recently Viewed Articles

Ringkjøbing Landbobank's Impressive Mid-Year Financial Update

Updated Category News Views 214

Ringkjøbing Landbobank's Financial Performance for 2025 In an exciting turn of events, Ringkjøbing Landbobank has shared its quarterly report for the first half of 2025, revealing remarkable financial outcomes that have caught the attention of analysts and stakeholders alike. Approval from Management The bank's board of directors, along with its general management, has...

Continue Reading
Mercy Medical Opens Center for Orthopedic Innovation

Updated Category News Views 42

Foot and Ankle Care Leap at Mercy Medical Mercy Medical Center in Baltimore is shaking things up in the orthopedic world. On August 10, 2026, they pulled the curtain back on the Center for Orthopedic Innovation, a place where the future of foot and ankle care is being molded. Led by renowned figure Dr. Lew Schon, they've crafted a cutting-edge space that’s all about...

Continue Reading
GECU's $4.9B Milestone: Navigating Regulatory Hurdles

Updated Category News Views 49

GECU's Bold Step: Merging with Bank of the Southwest When the gears of the financial world start grinding, there's no room for hesitation. GECU, one of the powerhouses when it comes to credit unions locally in Texas and New Mexico, has just snagged the regulatory green light to merge with the Bank of the Southwest. Talk about making moves—this transition's poised to...

Continue Reading
Taiwan's Economic Surge Driven by AI Innovations and Exports

Updated Category News Views 264

Economic Growth Outlook in Taiwan Taiwan has recently upgraded its economic growth forecast, reflecting its robust performance amid the ongoing AI revolution. As global appetite for AI-driven technology continues to surge, Taiwan is poised to reap substantial benefits. AI-Driven Exports In a remarkable display of economic resilience, Taiwan's exports skyrocketed almost...

Continue Reading
Exceptional Gold Intersections Reported at Keats Trench

Updated Category News Views 111

Major Discoveries in Gold Exploration New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) is thrilled to disclose impressive results from the second phase of channel sampling at Keats Trench as part of its ongoing exploration efforts at the Queensway Project. Highlights from Keats Trench Phase II The company noted exceptional intercepts in its sampling campaign, including...

Continue Reading